Bausch Health Companies BHC
NYSE BHC
$5.74 +0.01 (+0.26%)
As of: Oct 2, 2026 · 3:05 PM EDT

Bausch Health Companies (BHC) Non Operating Interest Expenses (2009 - 2026)

Updated

Bausch Health Companies (BHC) recorded Non Operating Interest Expenses of $396 million in Q2 2026, down 14.8% from $465 million a year earlier and down 1.5% from the prior quarter.

Analysis

Bausch Health Companies (BHC) Non Operating Interest Expenses (2009 - 2026) Analysis & Trends

On a TTM basis, Bausch Health Companies' Non Operating Interest Expenses came in at $1.61 billion as of Jun 30, 2026, up 8.7% year-over-year; for FY2025, it was $1.6 billion, up 15.6% from FY2024.

  • Annual Non Operating Interest Expenses has a five-year compound annual growth rate of 0.9% (FY2020 to FY2025).
  • Across earlier years, Non Operating Interest Expenses came in at $1.39 billion in FY2024 (+4.5%), $1.33 billion in FY2023 (-9.3%), $1.46 billion in FY2022 (+2.7%) and $1.43 billion in FY2021 (-7.0%).
  • The Q2 2026 figure is the lowest quarterly Non Operating Interest Expenses since Q1 2025.
  • On a year-over-year basis, Non Operating Interest Expenses rose in five of the last eight quarters, with growth averaging 8.1%.
  • Peak year-over-year performance for Non Operating Interest Expenses in the last five years was growth of 32.9% in Q2 2025, against a decline of 22.2% in Q2 2023 at the low end.
  • Per Business Quant, the preceding three quarters came in at $402 million (Q1 2026), $397 million (Q4 2025) and $412 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 281.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -462.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -435.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 673.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 247.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Bausch Health Companies 2.18 Bn -2.60 Bn 2.08 Bn 396.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 396.00 Mn
Mar 31, 2026 402.00 Mn
Dec 31, 2025 397.00 Mn
Sep 30, 2025 412.00 Mn
Jun 30, 2025 465.00 Mn
Mar 31, 2025 330.00 Mn
Dec 31, 2024 337.00 Mn
Sep 30, 2024 346.00 Mn
Jun 30, 2024 350.00 Mn
Mar 31, 2024 355.00 Mn
Dec 31, 2023 363.00 Mn
Sep 30, 2023 339.00 Mn
Jun 30, 2023 319.00 Mn
Mar 31, 2023 307.00 Mn
Dec 31, 2022 307.00 Mn
Sep 30, 2022 385.00 Mn
Jun 30, 2022 410.00 Mn
Mar 31, 2022 362.00 Mn
Dec 31, 2021 343.00 Mn
Sep 30, 2021 351.00 Mn
API Access

Bausch Health Companies Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=BHC&period=max&api_key=YOUR_API_KEY